Tenax Therapeutics (TENX) Operating Income (2016)
Historic Operating Income for Tenax Therapeutics (TENX) over the last 6 years, with Q4 2016 value amounting to -$42.2 million.
- Tenax Therapeutics' Operating Income fell 24887.04% to -$42.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was -$63.5 million, marking a year-over-year increase of 2819.9%. This contributed to the annual value of -$19.5 million for FY2024, which is 13675.01% down from last year.
- As of Q4 2016, Tenax Therapeutics' Operating Income stood at -$42.2 million, which was down 24887.04% from -$4.5 million recorded in Q3 2016.
- In the past 5 years, Tenax Therapeutics' Operating Income ranged from a high of $68.9 million in Q2 2012 and a low of -$74.1 million during Q2 2013
- In the last 4 years, Tenax Therapeutics' Operating Income had a median value of -$3.2 million in 2012 and averaged -$7.5 million.
- Its Operating Income has fluctuated over the past 5 years, first surged by 242467.64% in 2012, then plummeted by 24887.04% in 2016.
- Tenax Therapeutics' Operating Income (Quarter) stood at -$682843.0 in 2012, then tumbled by 10746.09% to -$74.1 million in 2013, then skyrocketed by 83.66% to -$12.1 million in 2015, then plummeted by 248.87% to -$42.2 million in 2016.
- Its last three reported values are -$42.2 million in Q4 2016, -$4.5 million for Q3 2016, and -$4.7 million during Q2 2016.